01:54 PM EDT, 07/23/2024 (MT Newswires) -- Health care stocks advanced Tuesday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both up 0.2%.

The iShares Biotechnology ETF (IBB) shed 0.3%.

In corporate news, Medpace ( MEDP ) shares tumbled 18%, a day after the company cut its 2024 revenue outlook.

SeaStar Medical ( ICU ) shares gained 2.6% after the company treated the first person in a commercial setting with Quelimmune, a therapy for acute kidney injury in pediatric patients.

Jaguar Health ( JAGX ) shares plunged 58% after initial results of a phase 3 trial assessing crofelemer for diarrhea prevention in people getting cancer treatment failed to meet the primary endpoint in all tumor types.